Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Completed 3Active not recruiting 1

Sponsor Class

OTHER 8INDUSTRY 4OTHER_GOV 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 28Thoracic 4Other solid neoplasm 3Tumor-Agnostic 2Gynecologic 1Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Advanced Non-Small Cell Lung Cancer 2Stomach Neoplasms 1Carcinoma, Transitional Cell 1

Interventions

Carboplatin 542Pemetrexed 392pembrolizumab 372Cisplatin 356Paclitaxel 285Docetaxel 240Gemcitabine 168Nivolumab 158Erlotinib Hydrochloride 147Bevacizumab 114atezolizumab 104osimertinib 99durvalumab 92Etoposide 90Gefitinib 68130-nm albumin-bound paclitaxel 65Cetuximab 64Ipilimumab 60Drug Therapy 51Topotecan 48Injections 44Afatinib 41tislelizumab 40Cyclophosphamide 39Albumin-Bound Paclitaxel 37Vinorelbine 36Crizotinib 34cemiplimab 31icotinib 26Radiotherapy 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × S 1 (combination) × Thoracic × Clear all
NCT05867121 2026-04-27

A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010

Genentech, Inc.

Phase 1 Active not recruiting
102 enrolled
GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Stomach Neoplasms

NCT02855125 2024-09-19

A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1

Taiho Oncology, Inc.

Phase 2 Completed
128 enrolled 16 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00651833 2024-09-03

Phase 2 Study of S-1 in Combination With Cisplatin as 1st Line Therapy in Advanced Non-Small Cell Lung Cancer

Taiho Oncology, Inc.

Phase 2 Completed
60 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

NCT00652561 2024-09-03

Phase 2 Study of S-1 as 2nd Line Therapy in Advanced Non-Small Cell Lung Cancer

Taiho Oncology, Inc.

Phase 2 Completed
57 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡